The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects. Home – CBSNews.com
About the Author
مجموعه ای از اخبار مهم سراسر جهان
